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Summary Although high-degree atrioventricular (AV) block in patients with a
history of syncope usually requires pacemaker implantation, therapeutic strate-
gies should also be considered. A 35-year-old man presented with complaints of
palpitations, nausea and dysgeusia. Since aged 30, the patient had experienced
three episodes of syncope. Holter monitoring showed transient high-degree AV block
(up to 5:4 block) associated with nausea, eructation and dysgeusia irrelevant to
posture as well as ventricular ectopic beats with palpitation. A head-up tilt test
revealed neurally mediated vasodepression but electrophysiological study showed
no abnormalities. These results indicated that his transient high-degree AV block
was functional, and syncope would have been because of neurally mediated vasode-
pression, not bradycardia. After administration of disopyramide at 300mg daily, the
symptoms subsided and ventricular ectopic beats and AV block disappeared. He has
been well for 20 months.
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ase report35-year-old man presented with complaints of
alpitations, nausea and dysgeusia. Since aged 30,
e had experienced three episodes of syncope that
ad followed discomfort during his day-time work in
gy. Published by Elsevier Ireland Ltd. All rights reserved.
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cope. As well, he complained of nausea, eructation
and dysgeusia around the time when AV block
occurred. However, the electrophysiological study
ﬁndings showed no abnormalities in his conduction
Table 1 Electrophysiological ﬁndings
Parameters Baseline After PAB
AA interval 772 625
AH interval 106 80
HV interval 56 54
Maximal SNRT (ms) 1085 —
1:1 AV conduction (ppm)170 —
Wenckebach rate (ppm) 160 —
ERP of AV node (ms) <290 (BCL 600ms) —
VA conduction none —Figure 1 Strips of Holter monit
a standing position. Physical examinations, chest X-
ray, 12-lead electrocardiogram, echocardiography
and exercise test were all normal, while Holter
monitoring showed several occurrences of transient
high-degree AV block (up to 5:4 block) mostly in
the morning (Fig. 1). The longest ventricular pause
was 4.4 s; associated symptoms were nausea, eruc-
tation and dysgeusia. His sinus rate was not slow
and noWenckebach-type AV block was seen. He also
complained of palpitations, but only when ectopic
ventricular beats occurred. During a head-up tilt
test after a 3-min loading of isoproterenol, he felt
presyncope developing with a sudden 33mmHg drop
of systolic blood pressure (121/49 to 88/29mmHg)
and a moderate decrease of heart rate but with-
out AV block (116—91 bpm). Carotid massage test
was negative. Electrophysiological study showed no
abnormalities in his conduction system (Table 1).
These results indicated that his transient high-
degree AV block was functional, and syncope would
have been because of neurally mediated vasode-
pression, not AV block. After administration of
disopyramide at 300mg daily, his symptoms disap-
peared and the frequency and degree of AV block
decreased. Holter ECG repeated 5 months after
discharge showed neither AV block nor ventricular
ectopic beats. He has been well for 20 months.Discussion
We reported a case of a patient with transient high-
degree AV block, palpitation, nausea and a historyshowing high-degree AV block.
f syncope successfully treated by disopyramide,
class I anti-arrhythmic drug. The chief com-
laints were palpitation and nausea. The former
as related to ventricular premature contraction.
he most important aspect of this case is whether
he AV block was related to his episodes of syn-
ope. Although the high-degree AV block might be
onsidered as linked to syncope, prudent evalua-
ion should be taken to decide a suitable strategy.
n the present case, head-up tilting test provoked
asodepressive presyncope (strictly, mixed type),
he symptom resembling that of his clinical syn-AA, atrio-atrio; AH, atrio-His; HV, His-ventricular; SNRT,
sinus node recovery time; AV, atrio-ventricular; ERP,
effective refractory period; VA, ventriculo-atrial; PAB,
pharmacologic autonomic block; ppm, pacing per
minute; BCL, basic cycle length.
Ds
t
E
o
i
t
o
i
b
r
s
a
D
a
e
s
t
n
n
o
e
s
o
s
d
b
a
u
o
a
t
i
w
n
c
v
a
n
c
u
t
e
a
h
R
[
[
[
[
[
[
[
[
[
Menozzi C, et al. Effect of etilefrine in preventing syn-isopyramide for transient atrioventricular block
ystem. Thus his syncope would have been related
o neurally mediated vasodepression, not AV block.
ven if his syncope were the result of a mixed type
f neurally mediated syncope, pacemaker therapy
s unlikely to have been helpful [1]. Although lit-
le is known about the mechanism and treatment
f transient AV block, several case reports have
llustrated the relationship between transient AV
lock and vagal hypersensitivity. According to these
eports, such functional AV block can cause the
udden onset of syncope, but an anti-cholinergic
gent precludes such a functional AV block [2—5].
isopyramide has a strong anti-cholinergic effect
nd after its administration, not only ventricular
ctopic beats but also AV block and associated
ymptoms disappeared. These ﬁndings also support
hat the transient AV block was related to vagal
erve activity. However, his heart rate was not sig-
iﬁcantly slow and there was no Wenckebach-type
f AV block around the time when he had sev-
ral episodes of transient AV block. These ﬁndings
uggest that the transient AV block was because
f vagal hypersensitivity rather than general vagal
urge. With regard to the syncope, it is unknown if
isopyramide precluded any recurrence of syncope
ecause we did not perform a head-up tilting test
fter disopyramide administration and the follow-
p period was relatively short. For medication
f neurally mediated syncope, midodrine, an -1
drenergic agonist, may be recommended rather
han disopyramide [6—8]. However, midodrine can
ncrease ectopic beats causing palpitations; as
ell, the usefulness of -1 adrenergic agonists has
ot been clearly established [9]. In the present
ase, disopyramide resolved palpitations involving
entricular ectopic beats, transient AV block and
ssociated symptoms. Fortunately there has been
o recurrence of syncope at this time. Although
o-morbidity of syncope and high-degree AV block
sually predisposes a patient to pacemaker implan-
Available online at www.61
ation, a prudent strategy should be ascertained for
ach case by careful analysis of a patient’s history,
nd after appropriate examinations and evaluations
ave been completed.
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